Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Preoperative chemotherapy plus lapatinib or trastuzumab or both in HER2-positive operable breast cancer (CHERLOB Trial).

× No keyword cloud information.

11 in total

1. Breast Cancer OncoGuia.

Authors: Paula Manchon; Josep M Borràs; Tàrsila Ferro; Josep Alfons Espinàs
Journal: Clin Transl Oncol Date: 2010-02 Impact factor: 3.405

Review 2. Treatment of HER2-positive breast cancer: current status and future perspectives.

Authors: Carlos L Arteaga; Mark X Sliwkowski; C Kent Osborne; Edith A Perez; Fabio Puglisi; Luca Gianni
Journal: Nat Rev Clin Oncol Date: 2011-11-29 Impact factor: 66.675

3. Targeted Therapy for Early and Locally Advanced Breast Cancer.

Authors: Michael Untch
Journal: Breast Care (Basel) Date: 2010-06-16 Impact factor: 2.860

Review 4. Heart Failure in Breast Cancer Survivors: Focus on Early Detection and Novel Biomarkers.

Authors: Dongqing Chen; Conagh Kelly; Tatt Jhong Haw; Janine M Lombard; Ina I C Nordman; Amanda J Croft; Doan T M Ngo; Aaron L Sverdlov
Journal: Curr Heart Fail Rep Date: 2021-11-03

Review 5. Present and future evolution of advanced breast cancer therapy.

Authors: Ricardo H Alvarez
Journal: Breast Cancer Res Date: 2010-10-22 Impact factor: 6.466

Review 6. Recent Advances in the Neoadjuvant Treatment of Breast Cancer.

Authors: Gábor Rubovszky; Zsolt Horváth
Journal: J Breast Cancer Date: 2017-06-26 Impact factor: 3.588

Review 7. Efficacy and safety of lapatinib and trastuzumab for HER2-positive breast cancer: a systematic review and meta-analysis of randomised controlled trials.

Authors: Zhi-Qiao Xu; Yan Zhang; Ning Li; Pei-Jie Liu; Ling Gao; Xin Gao; Xiao-Jing Tie
Journal: BMJ Open Date: 2017-03-13 Impact factor: 2.692

Preoperative chemotherapy plus lapatinib or trastuzumab or both in HER2-positive operable breast cancer (CHERLOB Trial).